NO952949L - Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider - Google Patents

Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider

Info

Publication number
NO952949L
NO952949L NO952949A NO952949A NO952949L NO 952949 L NO952949 L NO 952949L NO 952949 A NO952949 A NO 952949A NO 952949 A NO952949 A NO 952949A NO 952949 L NO952949 L NO 952949L
Authority
NO
Norway
Prior art keywords
inflammatory
oxindole
carboxamides
precursors
acyl
Prior art date
Application number
NO952949A
Other languages
English (en)
Other versions
NO952949D0 (no
Inventor
Wayne E Barth
Kelvin Cooper
Edward Fox Kleinman
Lawrence Alan Reiter
Ralph P Robinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO952949L publication Critical patent/NO952949L/no
Publication of NO952949D0 publication Critical patent/NO952949D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Det beskrives antiinflammatoriske og analgetiske oksindol-prodrugs med formel (I) hvor R10, R11, R12 og Ru er hydrogen, alkyl eller halogen, og R er metylenoksyalkanoyl, metylenoksyalkenoyl eller alkenoyl.
NO952949A 1993-01-26 1995-07-25 Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider NO952949D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/009,188 US5270331A (en) 1993-01-26 1993-01-26 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
PCT/US1993/009813 WO1994017061A1 (en) 1993-01-26 1993-10-20 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (2)

Publication Number Publication Date
NO952949L true NO952949L (no) 1995-07-25
NO952949D0 NO952949D0 (no) 1995-07-25

Family

ID=21736103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952949A NO952949D0 (no) 1993-01-26 1995-07-25 Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider

Country Status (35)

Country Link
US (1) US5270331A (no)
EP (1) EP0681580B1 (no)
JP (1) JP2703825B2 (no)
KR (1) KR0169827B1 (no)
CN (1) CN1052003C (no)
AP (1) AP443A (no)
AT (1) ATE155137T1 (no)
AU (1) AU678187B2 (no)
BR (1) BR9307768A (no)
CA (1) CA2152919C (no)
CZ (1) CZ181995A3 (no)
DE (1) DE69312093T2 (no)
DK (1) DK0681580T3 (no)
EG (1) EG20302A (no)
ES (1) ES2104187T3 (no)
FI (1) FI940365A7 (no)
GR (1) GR3024591T3 (no)
HR (1) HRP940034B1 (no)
HU (1) HUT69689A (no)
IL (1) IL108384A (no)
MA (1) MA23096A1 (no)
MX (1) MX9400677A (no)
MY (1) MY138629A (no)
NO (1) NO952949D0 (no)
NZ (1) NZ257278A (no)
OA (1) OA10563A (no)
PL (1) PL178857B1 (no)
RU (1) RU2124514C1 (no)
SI (1) SI9300567A (no)
SK (1) SK280929B6 (no)
TW (1) TW330935B (no)
UA (1) UA41348C2 (no)
WO (1) WO1994017061A1 (no)
YU (1) YU48796B (no)
ZA (1) ZA94463B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018194A1 (en) * 1993-02-09 1994-08-18 Pfizer Inc. Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents
WO1997013767A1 (de) * 1995-10-09 1997-04-17 Chemisch Pharmazeutische Forschungsgesellschaft Mbh Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren
KR20010041625A (ko) * 1998-03-06 2001-05-25 아스트라제네카 악티에볼라그 신규 용도
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
AU2002325614A1 (en) * 2001-08-16 2003-03-03 Pharmacon-Forschung Und Beratung Gmbh Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
CN101628842A (zh) * 2009-08-27 2010-01-20 中国人民解放军防化指挥工程学院 烷氧羰基甲氧基作为羧基保护基

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity
EP0365194B1 (en) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
MX9400677A (es) 1994-08-31
FI940365L (fi) 1994-07-27
GR3024591T3 (en) 1997-12-31
HRP940034A2 (en) 1996-08-31
DK0681580T3 (da) 1997-08-18
AU678187B2 (en) 1997-05-22
SK280929B6 (sk) 2000-09-12
KR0169827B1 (en) 1999-01-15
US5270331A (en) 1993-12-14
ES2104187T3 (es) 1997-10-01
CA2152919C (en) 1999-01-05
PL178857B1 (pl) 2000-06-30
BR9307768A (pt) 1995-11-21
EG20302A (en) 1998-10-31
TW330935B (en) 1998-05-01
JPH08501316A (ja) 1996-02-13
IL108384A (en) 1998-12-27
FI940365A0 (fi) 1994-01-25
RU95117091A (ru) 1997-06-27
HRP940034B1 (en) 2000-10-31
MA23096A1 (fr) 1994-10-01
YU2994A (sh) 1997-01-08
DE69312093D1 (de) 1997-08-14
EP0681580B1 (en) 1997-07-09
CA2152919A1 (en) 1994-08-04
EP0681580A1 (en) 1995-11-15
DE69312093T2 (de) 1997-10-30
JP2703825B2 (ja) 1998-01-26
AP443A (en) 1996-01-03
SI9300567A (en) 1994-09-30
SK91295A3 (en) 1995-12-06
CZ281046B6 (cs) 1996-06-12
WO1994017061A1 (en) 1994-08-04
PL309989A1 (en) 1995-11-13
CN1052003C (zh) 2000-05-03
NZ257278A (en) 1996-09-25
AP9300583A0 (en) 1993-10-31
IL108384A0 (en) 1994-04-12
UA41348C2 (uk) 2001-09-17
YU48796B (sh) 2000-03-21
CZ181995A3 (en) 1996-06-12
ATE155137T1 (de) 1997-07-15
HU9400209D0 (en) 1994-05-30
NO952949D0 (no) 1995-07-25
FI940365A7 (fi) 1994-07-27
HUT69689A (en) 1995-09-28
MY138629A (en) 2009-07-31
KR960700244A (ko) 1996-01-19
CN1097740A (zh) 1995-01-25
OA10563A (en) 2002-06-05
ZA94463B (en) 1995-07-24
AU5359894A (en) 1994-08-15
RU2124514C1 (ru) 1999-01-10

Similar Documents

Publication Publication Date Title
TW325458B (en) Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
NO924489D0 (no) Fremgangsmaate for fremstilling av enantioselektive fenylisoserin-derivater
CA2221114A1 (en) Atherosclerosis treatment
MY131641A (en) Indoline derivatives, process of preparation and use
LU92263I2 (fr) Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
AU6366386A (en) 3-vinyl- and 3- ethinyl-beta-carboline derivatives their production and their use as drugs
YU55200A (sh) Supstituisani bisindolmaleimidi za inhibiranje ćelijske proliferacije
NO952949L (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
NO891949L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser.
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
ES8104245A1 (es) Procedimiento para la preparacion de derivados de bencimida-zol
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
TW334340B (en) Preparation for pyrazolyl derivatives
JO1676B1 (en) Extra compounds indinol II
MX9802583A (es) Derivados de fenantridina, procedimiento para su preparacion y medicamentos que contienen derivadosde fenantridina.
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
MX9700712A (es) Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que los contienen.
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
NO307139B1 (no) Fremgangmåte ved fremstilling av 5,6-dihydroksy-2-amino- 1,2,3,4-tetrahydronaftalenderivater